Search by...
-
10JulThe AI Act: What will the impact be on the medical device industry?The European Parliament approved the “AI Act” (June 14, 2023), a proposal for a regulation providing a uniform legal framework for the use of artificial intelligence in the EU.
-
28JunDigital Therapeutics: EFPIA recommendations for access to digital therapies in the EUThe European Federation of Pharmaceutical Manufacturers & Associations ("EFPIA") published a report on Improving access to digital therapeutics in Europe, aiming to promote a structured approach to the regulation of digital therapeutics ("DTx") on the European market.
-
28JunDati anonimi e pseudonimi: cosa cambia per la ricerca dopo l’ultima sentenza della Corte UeIl Tribunale dell’Unione Europea si è espresso di recente sul tema della distinzione fra dati anonimi e pseudonimi. Il significato e l’impatto della sentenza sulla ricerca in ambito medico-scientifico
-
14JunNon-promotional communication: Boost for digital from the Farmindustria Code?The recent amendments to the Farmindustria Code on non-promotional drug interactions may boost pharmaceutical companies’ communication via digital and other channels.
-
8JunData protection enforcement in the healthcare: What can we learn from it?In recent years, since the GDPR was fully implemented and inspections focused on enforcement of the new rules began, the Italian Data Protection Authority has focused on breaches of the rules applicable to processing health data in the context of the Electronic Health Record, the Health File, and online medical reports.
-
6JunPortolano Cavallo doubles down on private equity with partner Gianpaolo Scandone joining as co-leadThe firm’s Private Equity practice to be led by partners Gianpaolo Scandone and Andrea GrittiArticle filed under: Private Equity
-
31MayProcessing health data on online platforms: The Garante rules on fairnessWith order no. 368 of November 10, 2022, the Italian Data Protection Authority ruled that the provider of an online platform aimed at connecting healthcare professionals with patients was in breach of the personal data protection rules provided by the GDPR in processing data via their platform.
-
22MayIntelligenza artificiale in azienda: le sfide della complianceIn qualsiasi settore si cerca di trarre valore dai dati personali che vengono trattati o di offrire servizi innovativi e personalizzati, e spesso lo si fa utilizzando l’IA. Questo pone importanti sfide in ambito privacy
-
12MayDrug advertising: New directions from EuropeEurope is not making any revolutionary changes when it comes to the advertising of medicines.
-
27AprGiuseppe Leozappa named the new Chief Marketing Officer of Portolano CavalloPortolano Cavallo is pleased to announce that Giuseppe Leozappa is joining the firm as Chief Marketing Officer.